| For: | Currie G, McKay G, Delles C. Biomarkers in diabetic nephropathy: Present and future. World J Diabetes 2014; 5(6): 763-776 [PMID: 25512779 DOI: 10.4239/wjd.v5.i6.763] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v5/i6/763.htm |
| Number | Citing Articles |
| 1 |
Zainab Mohamed Raouf, Wasan Naser. The expression patterns of Interleukin-26, Interleukin-35, and signal transducer and activator of transcription 1 in Type1 diabetes patients with diabetic nephropathy. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-026-11658-5
|
| 2 |
Hadeel Delman Najim, Mohammed Mahmood Mohammed, Abbas Mahdi Rahmah. The Impact of Empagliflozin on Renal Function and Kidney Injury Markers in Patients with Diabetic Nephropathy. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 2024; 7(1(Special)) doi: 10.54133/ajms.v7i1(Special).984
|
| 3 |
Hassan A. Shora, Ibrahim M. EL-Deen, Naglaa M. El-Lithy, Dina M. Abo-Elmatty, Salma M. Khirallah. Cytokeratin 18 and soluble cluster of differentiation-36: markers for nephropathy in patients with metabolic dysfunction-associated fatty liver disease. The Egyptian Journal of Internal Medicine 2025; 37(1) doi: 10.1186/s43162-025-00566-y
|
| 4 |
Lixia Lu, Yongtong Cao, Liang Ma, Xiaomu Kong. Mitochondrial DNA copy number in diabetic kidney disease: translational prospects and challenges. Archives of Physiology and Biochemistry 2026; doi: 10.1080/13813455.2026.2702001
|
| 5 |
Luigi Rossi, Maria Celeste Nicoletti, Monica Carmosino, Lisa Mastrofrancesco, Antonella Di Franco, Francesca Indrio, Rossella Lella, Luigi Laviola, Francesco Giorgino, Maria Svelto, Loreto Gesualdo, Giuseppe Procino. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy. Journal of Diabetes Research 2017; 2017 doi: 10.1155/2017/4360357
|
| 6 |
Hussein Qasim, Shaima' Dibian, Anas Hayajneh, Karis Khattab, Matteo Luigi Giuseppe Leoni , Giustino Varrassi. Histopathology of Diabetic Nephropathy: Beyond Glomerular Basement Membrane Thickening. Cureus 2025; doi: 10.7759/cureus.93497
|
| 7 |
Elfiani Elfiani, Anggelia Puspasari, Zulkhair Ali. Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications 2022; doi: 10.1007/978-3-030-81303-1_59-1
|
| 8 |
Laale F. Alawi, Sanjeev Dhakal, Sana E. Emberesh, Harshal Sawant, Anhar Hosawi, Unmesha Thanekar, Nadja Grobe, Khalid M. Elased. Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.602985
|
| 9 |
Huifang Dai, Lielie Zhu, Bilin Pan, Hai Li, ZhiJuan Dai, Xiaoyou Su. The relationship between serum γ-glutamyltransferase (GGT) and diabetic nephropathy in patients with type 2 diabetes mellitus: a cross-sectional study. Clinical and Experimental Medicine 2023; 23(7) doi: 10.1007/s10238-023-00991-9
|
| 10 |
Suman Sapkota, Saroj Khatiwada, Shrijana Shrestha, Nirmal Baral, Robin Maskey, Shankar Majhi, Lal Chandra, Madhab Lamsal, Martin Sedlacek. Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus. International Journal of Nephrology 2021; 2021 doi: 10.1155/2021/8884126
|
| 11 |
Enrique Luna, Álvaro Álvarez, Jorge Rodriguez-Sabiñón, Juan Villa, Teresa Giraldo, Maria Victoria Martín, Eva Vázquez, Noemi Fernández, Belén Ruiz, Guadalupe Garcia-Pino, Coral Martínez, Lilia Azevedo, Rosa María Diaz, Nicolas Roberto Robles, Guillermo Gervasini. Long-Term Effect of Semaglutide on the Glomerular Filtration Rate Slope in High-Risk Patients with Diabetic Nephropathy: Analysis in Real-World Clinical Practice. Pharmaceutics 2025; 17(7) doi: 10.3390/pharmaceutics17070943
|
| 12 |
Elahe Soltani-Fard, Sina Taghvimi, Farzaneh Karimi, Farzaneh Vahedi, Seyyed Hossein Khatami, Hamid Behrooj, Mojdeh Deylami Hayati, Ahmad Movahedpour, Hassan Ghasemi. Urinary biomarkers in diabetic nephropathy. Clinica Chimica Acta 2024; 561 doi: 10.1016/j.cca.2024.119762
|
| 13 |
Mona Hussein El-Samahy, AA Adly, Yasmine Ibrahim Elhenawy, EA Ismail, Shaimaa Abdelmalik Pessar, Mohamed El-Sayed Mowafy, Mohammed Salah Saad, Hossam Hassan Mohammed. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes. Journal of Diabetes and its Complications 2018; 32(2) doi: 10.1016/j.jdiacomp.2017.10.014
|
| 14 |
Mohamed Hassan, Mohamed M. Aboelnaga, Mohamed Al-arman, Elsayed Z. Hatata. Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2021; 15(4) doi: 10.1016/j.dsx.2021.05.025
|
| 15 |
Wedad Alruwaytie, Amal Mohamad Husein Mackawy. Endogenous Non-Invasive Early Biomarkers for Diabetic Nephropathy in Type 2 Diabetic Saudi Patients: A Case Control Study. SN Comprehensive Clinical Medicine 2025; 7(1) doi: 10.1007/s42399-025-01985-2
|
| 16 |
Association of the ACE (rs1800764) Polymorphism with Risk of Diabetic Kidney Disease in Saudi Arabian Population: A Pilot Study using the PCR-RFLP Method. Cytology and Genetics 2019; 53(6) doi: 10.3103/S0095452719060069
|
| 17 |
Ibrahim Abdulsada, Zain Alabdeen Obaid, Farah Almerza, Mays Alwaeli, Anmar Al-Elayawi, Taha Al-Dayyeni, Harir Al-Tuhafy. Determination of Diabetes-associated Cardiovascular Autonomic Neuropathy Risk Factors among Insulin and Non-insulin Dependent Diabetics. The Journal of Medical Research 2023; 9(6) doi: 10.31254/jmr.2023.9603
|
| 18 |
Sandra Božičević, Marijana Vučić Lovrenčić, Lea Smirčić Duvnjak. Diagnostic challenges of diabetic kidney disease. Biochemia medica 2023; 33(3) doi: 10.11613/BM.2023.030501
|
| 19 |
Naseer Ullah Khan, Jing Lin, Xukun Liu, Haiying Li, Wei Lu, Zhuning Zhong, Huajie Zhang, Muhammad Waqas, Liming Shen. Insights into predicting diabetic nephropathy using urinary biomarkers. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2020; 1868(10) doi: 10.1016/j.bbapap.2020.140475
|
| 20 |
Sara Nunes, André Alves, Inês Preguiça, Adelaide Barbosa, Pedro Vieira, Fernando Mendes, Diana Martins, Sofia D. Viana, Flávio Reis. Crescent-Like Lesions as an Early Signature of Nephropathy in a Rat Model of Prediabetes Induced by a Hypercaloric Diet. Nutrients 2020; 12(4) doi: 10.3390/nu12040881
|
| 21 |
Astha Jaiswal, Phool Chandra. Implications of Endothelin-1 Antagonist, ACE Inhibitor and Statin on Experimentally Induced Hyperlipidemic Nephropathy in Rats. Oriental Journal Of Chemistry 2025; 41(5) doi: 10.13005/ojc/410518
|
| 22 |
Federica Storti, Jennifer Pulley, Pascal Kuner, Markus Abt, Ulrich F. O. Luhmann. Circulating Biomarkers of Inflammation and Endothelial Activation in Diabetic Retinopathy. Translational Vision Science & Technology 2021; 10(12) doi: 10.1167/tvst.10.12.8
|
| 23 |
Zhi Su, Deborah Widomski, Ji Ma, Marian Namovic, Arthur Nikkel, Laura Leys, Lauren Olson, Katherine Salte, Diana Donnelly-Roberts, Timothy Esbenshade, Steve McGaraughty. Longitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic Nephropathy. American Journal of Nephrology 2016; 44(5) doi: 10.1159/000449324
|
| 24 |
Gemma Currie, Sheon Mary, Christian Delles. Is there a role for proteomics in diabetic renal disease?. Nephrology Dialysis Transplantation 2020; 35(7) doi: 10.1093/ndt/gfz017
|
| 25 |
Shilin Li, Antoine Brault, Mayra Sanchez Villavicencio, Pierre S. Haddad. Rhododendron groenlandicum(Labrador tea), an antidiabetic plant from the traditional pharmacopoeia of the Canadian Eastern James Bay Cree, improves renal integrity in the diet-induced obese mouse model. Pharmaceutical Biology 2016; 54(10) doi: 10.3109/13880209.2015.1137953
|
| 26 |
Qing Zhang, Yongqiang Ji, Wei Lv, Tianwei He, Jianping Wang. Protective effects of leflunomide on renal lesions in a rat model if diabetic nephropathy. Renal Failure 2016; 38(1) doi: 10.3109/0886022X.2015.1105024
|
| 27 |
Sahana Shetty, Renuka Suvarna, Avivar Awasthi, Mohan V. Bhojaraja, Joseph M. Pappachan. Emerging Biomarkers and Innovative Therapeutic Strategies in Diabetic Kidney Disease: A Pathway to Precision Medicine. Diagnostics 2025; 15(8) doi: 10.3390/diagnostics15080973
|
| 28 |
P. J. Padmini, V. Ashok. Urine neutrophil gelatinase-associated lipocalin as an early biochemical marker of microalbuminuria in predicting early kidney damage in patients with type 2 diabetes mellitus. The Ukrainian Biochemical Journal 2021; 93(6) doi: 10.15407/ubj93.06.055
|
| 29 |
Valeria Maeda-Gutiérrez, Carlos E. Galván-Tejada, Jorge I. Galván-Tejada, Miguel Cruz, José M. Celaya-Padilla, Hamurabi Gamboa-Rosales, Alejandra García-Hernández, Huizilopoztli Luna-García, Klinge Orlando Villalba-Condori. Evaluating Feature Selection Methods for Accurate Diagnosis of Diabetic Kidney Disease. Biomedicines 2024; 12(12) doi: 10.3390/biomedicines12122858
|
| 30 |
Robab Aboutorabi, Golrokh Hariri, Aida Bakhshi, Majid Alizadeh, Hassan Mehrad-Majd. Reply to: Significance of serum spexin in diabetic nephropathy: A reassessment of literature citation and data analysis.. International Urology and Nephrology 2025; 58(2) doi: 10.1007/s11255-025-04690-0
|
| 31 |
Robab Aboutorabi, Golrokh Hariri, Aida Bakhshi, Majid Alizadeh, Hassan Mehrad-Majd. Association between serum spexin levels and diabetic nephropathy in patients with type 2 diabetes: a cross-sectional study. International Urology and Nephrology 2025; 57(11) doi: 10.1007/s11255-025-04556-5
|
| 32 |
BenibobaJenewari Eleki, PedroC Emem-Chioma. Prevalence and Spectrum of Albuminuria among Type 2 Diabetic Patients in a Tertiary Health-care Facility in Southern Nigeria. Nigerian Journal of Medicine 2023; 32(1) doi: 10.4103/NJM.NJM_119_22
|
| 33 |
Dongmei Sun, Yifei Hu, Yongjun Ma, Huabin Wang. Predictive role of serum C-peptide in new-onset renal dysfunction in type 2 diabetes: a longitudinal observational study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1227260
|
| 34 |
Khalid Al-Rubeaan, Khalid Siddiqui, Mohammed A. Al-Ghonaim, Amira M. Youssef, Ahmed H. Al-Sharqawi, Dhekra AlNaqeb. Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02421-9
|
| 35 |
Khemender Lidoo, Rupinder Kaur, Ravinder Singh, Sarita Jangra, Thakur Gurjeet Singh, Pratima Kumari. The gut-kidney axis revisited: Integrating gut microbiota, autophagy and metabolomics in chronic kidney disease. International Immunopharmacology 2026; 187 doi: 10.1016/j.intimp.2026.117238
|
| 36 |
Haochen Liu, Xiaomiao Li, Ke Shi, Fengyu Lei, Ziyan Wang, Ziyuan Gao, Yunxi Liu, Jing Zhu, Jiajia Zhai, Yi Zhang, Xinyu Li, Shiyu Wang, Yu Niu, Louyan Ma, Tianxiao Zhang. Characterizing clinical risk profiles of major complications in type 2 diabetes mellitus using deep learning algorithms. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1657366
|
| 37 |
Dhamodharan Umapathy, Sireesh Dornadula, Ezhilarasi Krishnamoorthy, Vairamani Mariappanadar, Vijay Viswanathan, Kunka Mohanram Ramkumar. YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines. Immunobiology 2018; 223(11) doi: 10.1016/j.imbio.2018.07.020
|
| 38 |
Samuel N. Uwaezuoke, Ugo N. Chikani, Ngozi R. Mbanefo. Advances in Nephropathy. 2018; doi: 10.5772/intechopen.79331
|
| 39 |
Giuseppe Penno, Eleonora Russo, Monia Garofolo, Giuseppe Daniele, Daniela Lucchesi, Laura Giusti, Veronica Sancho Bornez, Cristina Bianchi, Angela Dardano, Roberto Miccoli, Stefano Del Prato. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus. Diabetologia 2017; 60(6) doi: 10.1007/s00125-017-4251-1
|
| 40 |
Yik Pui Tsang, Kayenat S. Aryeh, Kai Wang, Jonathan Himmelfarb, Catherine K. Yeung, Edward J. Kelly. Enhancing therapeutic strategies and drug development for patients with kidney disease. Expert Opinion on Drug Safety 2026; 25(1) doi: 10.1080/14740338.2025.2525970
|
| 41 |
Yujie Jin, Yan Ma, Yan Yao, Mengru Wang, Chunchen Ni, Shujuan Shang, Yongxin Cui, Xinyu Wang, Ye Ling, Yumeng Sun, Qirui Pei, Shiqiang Liu, Lizhuo Wang, Jialin Gao, Hannah Wesley. Advances in the Identification of Novel Urinary Biomarkers for Diabetic Kidney Disease. Journal of Diabetes Research 2026; 2026(1) doi: 10.1155/jdr/7990072
|
| 42 |
Mosa Osama, Rizk Mahmoud, Asmaa Said. Microalbuminuria besides to urinary enzymatic protein levels increase in Diabetic kidney disease with type II diabetics. Sanamed 2018; 13(2) doi: 10.24125/sanamed.v13i2.254
|
| 43 |
Alfonso Parejo Martín, María T. Carande del Río, Nicolas R. Robles, Sergio Gómez Vera, María Jesús Fernández Cavada, Cristina Xavier Aller, Beatriz Sacristán Enciso, Juan López Gómez. Cadena ligera libre kappa como predictor de daño tubular en primera orina de la mañana. Nefrología 2026; 46(6) doi: 10.1016/j.nefro.2026.501538
|
| 44 |
Khalid Siddiqui, Salini Scaria Joy, Shaik Sarfaraz Nawaz, Dhekra Alnaqeb, Muhammad Mujammami, Khalid Al-Rubeaan. Association of urinary non-albumin protein with the different urinary marker for glomerular and tubular damage in patients with type 2 diabetes. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-01906-6
|
| 45 |
Leena Mamilly, Lucy D. Mastrandrea, Claudia Mosquera Vasquez, Brett Klamer, Mahmoud Kallash, Ahmad Aldughiem. Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.669954
|
| 46 |
Akiko Sakurai, Hiroyuki Ono, Arisa Ochi, Motokazu Matsuura, Sakiya Yoshimoto, Seiji Kishi, Taichi Murakami, Tatsuya Tominaga, Kojiro Nagai, Hideharu Abe, Toshio Doi, Utpal Sen. Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy. PLOS ONE 2019; 14(5) doi: 10.1371/journal.pone.0216788
|
| 47 |
Zoi Kleinaki, Stella Kapnisi, Sofia-Andriani Theodorelou-Charitou, Ilias P. Nikas, Stavroula A. Paschou. Type 2 diabetes mellitus management in patients with chronic kidney disease: an update. Hormones 2020; 19(4) doi: 10.1007/s42000-020-00212-y
|
| 48 |
G. Currie, C. Delles. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy. Current Diabetes Reports 2016; 16(11) doi: 10.1007/s11892-016-0798-3
|
| 49 |
Agnieszka Los-Stegienta, Anna Borkowska, Katarzyna Cypryk. Assessment of microvascular function using a novel technique Flow Mediated Skin Fluorescence (FMSF) in patients with diabetic kidney disease: A preliminary study. Microvascular Research 2022; 144 doi: 10.1016/j.mvr.2022.104417
|
| 50 |
M. V. Shestakova. Diabetes mellitus and chronic kidney disease: Possibilities of prediction, early diagnosis, and nephroprotection in the 21st century. Terapevticheskii arkhiv 2016; 88(6) doi: 10.17116/terarkh201688684-88
|
| 51 |
Hicham Benabdelkamel, Afshan Masood, Meshail Okla, Mohammed Y. Al-Naami, Assim A. Alfadda. A Proteomics-Based Approach Reveals Differential Regulation of Urine Proteins between Metabolically Healthy and Unhealthy Obese Patients. International Journal of Molecular Sciences 2019; 20(19) doi: 10.3390/ijms20194905
|
| 52 |
Sidra Khalid, Shahid Bashir, Riffat Mehboob, Humaira Waseem, Imran Shahid, Abdullah R. Alzahrani, Uzma Malik, Hani Shalabi, Abdulhadi I Bima, Siti Sarah Maidin, Ragdah Hussain Arif, Hussam M Alim. Comparison of Diabetic Nephropathy Markers in Diabetic Patients With Insomnia Before and After Potassium and Magnesium Supplementation: A Randomized Controlled Trial. Health Science Reports 2026; 9(1) doi: 10.1002/hsr2.71738
|
| 53 |
Yanjuan Hou, Yonghong Shi, Baosheng Han, Xuqian Liu, Xi Qiao, Yue Qi, Lihua Wang. The antioxidant peptide SS31 prevents oxidative stress, downregulates CD36 and improves renal function in diabetic nephropathy. Nephrology Dialysis Transplantation 2018; 33(11) doi: 10.1093/ndt/gfy021
|
| 54 |
Benan Kasapoglu, Cansel Turkay, Kadir Serkan Yalcın, Salih Boga, Alper Bozkurt. Increased microalbuminuria prevalence among patients with nonalcoholic fatty liver disease. Renal Failure 2016; 38(1) doi: 10.3109/0886022X.2015.1106845
|
| 55 |
O K Vikulova, Z T Zuraeva, O V Michaleva, L V Nikankina, M Sh Shamkhalova, M V Shestakova, I I Dedov. Renal effects of glucagon-like peptide receptor agonists in patients with type 1 diabetes mellitus. Terapevticheskii arkhiv 2018; 90(6) doi: 10.26442/terarkh201890659-64
|
| 56 |
Deyuan Zhang, Shandong Ye, Tianrong Pan. The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes. PeerJ 2019; 7 doi: 10.7717/peerj.7079
|
| 57 |
Astha Jaiswal, Phool Chandra. Implication of BQ-123, Valsartan and Atorvastatin on Hyperlipidemia Induced Nephropathy in Rats: A Preclinical Evaluation. Oriental Journal Of Chemistry 2026; 2(42) doi: 10.13005/ojc/420231
|
| 58 |
Jun-Ya Kaimori, Yoshitaka Isaka, Masaki Hatanaka, Satoko Yamamoto, Naotsugu Ichimaru, Akihiko Fujikawa, Hiroshi Shibata, Akira Fujimori, Sosuke Miyoshi, Takashi Yokawa, Kagayaki Kuroda, Toshiki Moriyama, Hiromi Rakugi, Shiro Takahara. Visualization of kidney fibrosis in diabetic nephropathy by long diffusion tensor imaging MRI with spin-echo sequence. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06111-4
|
| 59 |
Thapelo Mbhele, Donald M. Tanyanyiwa, Refilwe J. Moepya, Sindeep Bhana, Maya M. Makatini. Relationship between amino acid ratios and decline in estimated glomerular filtration rate in diabetic and non-diabetic patients in South Africa. African Journal of Laboratory Medicine 2021; 10(1) doi: 10.4102/ajlm.v10i1.1398
|
| 60 |
Axel C Carlsson, Johan Sundström, Juan Jesus Carrero, Stefan Gustafsson, Markus Stenemo, Anders Larsson, Lars Lind, Johan Ärnlöv. Use of a proximity extension assay proteomics chip to discover new biomarkers associated with albuminuria. European Journal of Preventive Cardiology 2017; 24(4) doi: 10.1177/2047487316676134
|
| 61 |
Pavana A, Vasudha K C, Pramila Kalra. Urinary transferrin as early marker of renal damage in type II diabetes mellitus: A case–control study. International Journal of Clinical Biochemistry and Research 2021; 8(1) doi: 10.18231/j.ijcbr.2021.008
|
| 62 |
Setah Naif Alotaibi, Ghedeir M. Alshammari, Nawal A. Albadr, Mohammed Abdo Yahya. Therapeutic Potential of Cinnamic Acid as an SGLT2 Inhibitor in Mitigating Diabetic Nephropathy in a Rat Model of Type 2 Diabetes. Molecular Nutrition & Food Research 2025; 69(20) doi: 10.1002/mnfr.70164
|
| 63 |
Jamal Ahmad. Management of diabetic nephropathy: Recent progress and future perspective. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2015; 9(4) doi: 10.1016/j.dsx.2015.02.008
|
| 64 |
Sreenath Sreedharan, Mohandas M. K., Vismaya K. B., Nikhil Raju. Non-diabetic Kidney Disease in Type 2 Diabetes: From Kidney Biopsy to Precision Medicine. Cureus 2026; doi: 10.7759/cureus.100716
|
| 65 |
C. Hizel, J. Tremblay, G. Bartlett, P. Hamet. Progress and Challenges in Precision Medicine. 2017; doi: 10.1016/B978-0-12-809411-2.00001-5
|
| 66 |
Gemma Currie, Christian Delles. Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients. Current Hypertension Reports 2016; 18(7) doi: 10.1007/s11906-016-0661-6
|
| 67 |
E. B. Popykhova, A. N. Ivanov, T. V. Stepanova, D. D. Lagutina, A. A. Savkina. Diabetic Nephropathy – possibilities of early laboratory diagnostics and course prediction (review of literature). Russian Clinical Laboratory Diagnostics 2021; 66(10) doi: 10.51620/0869-2084-2021-66-10-593-602
|
| 68 |
Lilia Abbad, Niki Prakoura, Arthur Michon, Rym Chalghoumi, Simone Reichelt-Wurm, Miriam C. Banas, Christos Chatziantoniou. Role of Periostin and Nuclear Factor-κB Interplay in the Development of Diabetic Nephropathy. Cells 2022; 11(14) doi: 10.3390/cells11142212
|
| 69 |
Arlinda R. Driza, Georgia V. Kapoula, Pantelis G. Bagos. Urinary N-Acetyl-β-d-glucosaminidase (uNAG) as an Indicative Biomarker of Early Diabetic Nephropathy in Patients with Diabetes Mellitus (T1DM, T2DM): A Systematic Review and Meta-Analysis. Diabetology 2021; 2(4) doi: 10.3390/diabetology2040025
|
| 70 |
Elizabeth Sorvor, William K. B. A. Owiredu, Perditer Okyere, Max Efui Annani-Akollor, Sampson Donkor, Richard Bannor, Felix B.K. Sorvor, Richard K.D. Ephraim. Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis. Frontiers in Clinical Diabetes and Healthcare 2022; 3 doi: 10.3389/fcdhc.2022.881202
|
| 71 |
Alina Golea-Secara, Cristian Munteanu, Mirela Sarbu, Octavian M Cretu, Silvia Velciov, Adrian Vlad, Flaviu Bob, Florica Gadalean, Cristina Gluhovschi, Oana Milas, Anca Simulescu, Maria Mogos-Stefan, Mihaela Patruica, Ligia Petrica, Alina D Zamfir. Urinary Proteins Detected Using Modern Proteomics Intervene in Early Type 2 Diabetic Kidney Disease – A Pilot Study. Biomarkers in Medicine 2020; 14(16) doi: 10.2217/bmm-2020-0308
|
| 72 |
Lin Mu, Nan Chen, Yakun Chen, Zhifen Yang, Huandi Zhou, Shan Song, Yonghong Shi, Vikas Kumar Roy. Blocking REDD1/TXNIP Complex Ameliorates HG-Induced Renal Tubular Epithelial Cell Apoptosis and EMT through Repressing Oxidative Stress. International Journal of Endocrinology 2022; 2022 doi: 10.1155/2022/6073911
|
| 73 |
Lay-Harn Gam. Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications 2023; doi: 10.1007/978-3-031-08014-2_42
|
| 74 |
Diğdem Bezen, Eren Vurgun, Hasan Dursun. Evaluation of urinary haptoglobin level as a biomarker of diabetic nephropathy in children with type 1 diabetes. Pediatric Nephrology 2023; 38(11) doi: 10.1007/s00467-023-06012-x
|
| 75 |
Carole G. Campion, Oraly Sanchez-Ferras, Sri N. Batchu. Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy. Canadian Journal of Kidney Health and Disease 2017; 4 doi: 10.1177/2054358117705371
|
| 76 |
Ahmed Olatunde, Kaliyaperumal Saravanan, Olalekan Bukunmi Ogunro, Mayowa Shakirdeen Obidola, Abdullahi Jakwa, Abdulazeez Lawal, Abdulhakeem Akano Shittu, Habibu Tijjani, Huzaifa Umar, Dilber Uzun Ozsahin, Ayuba Mugana, Siddhaiyan Elavarsi, Ganesan Revathi. Insights into diabetic nephropathy biomarkers with focus on existing indices and potential future developments. Discover Medicine 2025; 2(1) doi: 10.1007/s44337-025-00333-6
|
| 77 |
Ali Hussein Mohammed, Ahmed Sedky, Hisham A. Alghany Algahlan, Amr M. Zaghloul. Assessment of Urinary Albumin/Creatinine Ratio in Non-Obese Non-Diabetic Patients with Nonalcoholic Fatty Liver Disease. Open Journal of Gastroenterology 2020; 10(04) doi: 10.4236/ojgas.2020.104007
|
| 78 |
Nicholas J Radcliffe, Jas‐mine Seah, Michele Clarke, Richard J MacIsaac, George Jerums, Elif I Ekinci. Clinical predictive factors in diabetic kidney disease progression. Journal of Diabetes Investigation 2017; 8(1) doi: 10.1111/jdi.12533
|
| 79 |
Liqun Ma, Rongguo Fu, Zhaoyang Duan, Jiamei Lu, Jie Gao, Lifang Tian, Zhian Lv, Zhao Chen, Jin Han, Lining Jia, Li Wang. Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat. Pathology - Research and Practice 2016; 212(4) doi: 10.1016/j.prp.2016.02.001
|
| 80 |
Xin-Ping Zhao, Shiao-Ying Chang, Min-Chun Liao, Chao-Sheng Lo, Isabelle Chenier, Hongyu Luo, Jean-Louis Chiasson, Julie R. Ingelfinger, John S. D. Chan, Shao-Ling Zhang. Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24220-6
|
| 81 |
Merita Rroji, Flaviu Bob, Lorenzo Lo Cicero, Andreja Figurek, Goce Spasovski. Biomarkers in Diabetic Kidney Disease: Early Detection, Prognostic Assessment, and Integration with Multi-Omics Signatures. Life 2026; 16(7) doi: 10.3390/life16071164
|
| 82 |
Astha Jaiswal, Bhupesh Chandra Semwal, Sonia Singh. Effect of Captopril and BQ123 Endothelin-1 Antagonist on Experimentally Induced Hyperlipidemic Nephropathy in Rats. Recent Patents on Biotechnology 2023; 17(2) doi: 10.2174/1872208316666220629150347
|
| 83 |
Qian Li, Bao Li, Chang-Liang Lu, Jing-Ye Wang, Min Gao, Wei Gao. LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma. Cancer Gene Therapy 2021; 28(9) doi: 10.1038/s41417-020-00267-4
|
| 84 |
Rajesh Jha, Sara Lopez-Trevino, Haritha R. Kankanamalage, Jay C. Jha. Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions. Biomedicines 2024; 12(5) doi: 10.3390/biomedicines12051098
|
| 85 |
Haoxue Gao, Xiaoyi Yu, Runbin Sun, Na Yang, Jun He, Mingxue Tao, Huilin Gu, Caixia Yan, Jiye Aa, Guangji Wang. Quantitative GC–MS assay of citric acid from humans and db/db mice blood serum to assist the diagnosis of diabetic nephropathy. Journal of Chromatography B 2018; doi: 10.1016/j.jchromb.2017.12.021
|
| 86 |
Danfeng Liu, Xiaojie Chen, Weiting He, Min Lu, Qiuling Li, Shaogui Zhang, Jianteng Xie, Yifan Zhang, Wenjian Wang. Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy. Integrative Medicine in Nephrology and Andrology 2024; 11(4) doi: 10.1097/IMNA-D-23-00029
|
| 87 |
Naveenah Udaya Surian, Arsen Batagov, Andrew Wu, Wen Bin Lai, Yan Sun, Yong Mong Bee, Rinkoo Dalan. A digital twin model incorporating generalized metabolic fluxes to identify and predict chronic kidney disease in type 2 diabetes mellitus. npj Digital Medicine 2024; 7(1) doi: 10.1038/s41746-024-01108-6
|
| 88 |
|
| 89 |
Kamal Taha, Ramana Davuluri, Paul Yoo, Jesse Spencer, Lars Kaderali. Personizing the prediction of future susceptibility to a specific disease. PLOS ONE 2021; 16(1) doi: 10.1371/journal.pone.0243127
|
| 90 |
Tomás P. Griffin, William Patrick Martin, Nahidul Islam, Timothy O’Brien, Matthew D. Griffin. The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease. Current Diabetes Reports 2016; 16(5) doi: 10.1007/s11892-016-0734-6
|
| 91 |
Rama Rao Nadendla, Khairunnisa K., Namra Aziz, Chandana Pyne, Uttam Prasad Panigrahy, Pranay Wal, Mrunalini Harish Kulkarni, Azhar Rasheed. An Updated Review on Diabetic Nephropathy: Potential Mechanisms, Biomarkers, Therapeutic Targets and Interventional Therapies. Current Diabetes Reviews 2025; 21(9) doi: 10.2174/0115733998291920240611063402
|
| 92 |
Claudia Banescu, Iuliana Magdalena Starcea, Carmen Muntean. Diabetic kidney disease in pediatric patients: A current review. World Journal of Diabetes 2022; 13(8): 587-599 doi: 10.4239/wjd.v13.i8.587
|
| 93 |
Sonia Mota-Zamorano, Nicolás R. Robles, Luz M. González, José M. Valdivielso, Juan Lopez-Gomez, Bárbara Cancho, Guadalupe García-Pino, Guillermo Gervasini. Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy. Journal of Clinical Medicine 2021; 10(17) doi: 10.3390/jcm10173980
|
| 94 |
Ziyi Feng, Xiaomu Kong, Liang Ma. DNA methylation biomarkers in diabetic kidney disease: insights and implications. Molecular Genetics and Genomics 2025; 300(1) doi: 10.1007/s00438-025-02277-z
|
| 95 |
Mayara Karla dos Santos Nunes, Alexandre Sérgio Silva, Isabella Wanderley de Queiroga Evangelista, João Modesto Filho, Cecília Neta Alves Pegado Gomes, Rayner Anderson Ferreira do Nascimento, Rafaella Cristhine Pordeus Luna, Maria José de Carvalho Costa, Naila Francis Paulo de Oliveira, Darlene Camati Persuhn. Hypermethylation in the promoter of the MTHFR gene is associated with diabetic complications and biochemical indicators. Diabetology & Metabolic Syndrome 2017; 9(1) doi: 10.1186/s13098-017-0284-3
|
| 96 |
Vasilios G Athyros, Niki Katsiki, Asterios Karagiannis, Dimitri P Mikhailidis. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?. Expert Opinion on Pharmacotherapy 2015; 16(10) doi: 10.1517/14656566.2015.1053464
|
| 97 |
Shivangi Dwivedi, Mukesh Singh Sikarwar. Diabetic Nephropathy: Pathogenesis, Mechanisms, and Therapeutic
Strategies. Hormone and Metabolic Research 2025; 57(01) doi: 10.1055/a-2435-8264
|
| 98 |
Alfonso Parejo Martín, María T. Carande del Río, Nicolas R. Robles, Sergio Gómez Vera, María Jesús Fernández Cavada, Cristina Xavier Aller, Beatriz Sacristán Enciso, Juan López Gómez. Kappa free light chain as a predictor of tubular damage in first morning urine. Nefrología (English Edition) 2026; 46(6) doi: 10.1016/j.nefroe.2026.501538
|
| 99 |
Jing Ning, Zhicong Xiang, Chongxiang Xiong, Qin Zhou, Xin Wang, Hequn Zou. <p>Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria</p>. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; doi: 10.2147/DMSO.S250347
|
| 100 |
Raja Ramachandran, Parul C Gupta, Arvind Kumar Morya, Nitin K Menia. Ocular biomarkers in diabetes mellitus with diabetic kidney disease: A minireview. World Journal of Nephrology 2025; 14(3): 109470 doi: 10.5527/wjn.v14.i3.109470
|
| 101 |
Umm E. Habiba, Nasar Khan, David Lawrence Greene, Sabiha Shamim, Amna Umer. The therapeutic effect of mesenchymal stem cells in diabetic kidney disease. Journal of Molecular Medicine 2024; 102(4) doi: 10.1007/s00109-024-02432-w
|
| 102 |
Xiaoting Duan, Cheng Chen, Xiaoli Liu, Taoxia Wang, Shuning Feng, Jianwei Li, Guiying Li. Interference of periostin attenuates pathological changes, proinflammatory markers and renal fibrosis in diabetic kidney injury. Genes & Genomics 2023; 45(11) doi: 10.1007/s13258-023-01400-x
|
| 103 |
Lang Han, Xiaojiao Chen, Dianwei Wan, Min Xie, Shurui Ouyang. One anastomosis gastric bypass ameliorates diabetic nephropathy via regulating the GLP-1-mediated Sirt1/AMPK/PGC1α pathway. Clinical and Experimental Nephrology 2024; 28(10) doi: 10.1007/s10157-024-02516-4
|
| 104 |
Cristina Gluhovschi, Gheorghe Gluhovschi, Ligia Petrica, Romulus Timar, Silvia Velciov, Ioana Ionita, Adriana Kaycsa, Bogdan Timar. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy. Journal of Diabetes Research 2016; 2016 doi: 10.1155/2016/4626125
|
| 105 |
Sander De Bruyne, Jo Van Dorpe, Jonas Himpe, Wim Van Biesen, Sigurd Delanghe, Marijn M. Speeckaert, Joris R. Delanghe. Detection and Characterization of a Biochemical Signature Associated with Diabetic Nephropathy Using Near-infrared Spectroscopy on Tissue Sections. Journal of Clinical Medicine 2019; 8(7) doi: 10.3390/jcm8071022
|
| 106 |
Koen W. Streng, Hans L. Hillege, Jozine M. ter Maaten, Dirk J. van Veldhuisen, Kenneth Dickstein, Nilesh J. Samani, Leong L. Ng, Marco Metra, Gerasimos S. Filippatos, Piotr Ponikowski, Faiez Zannad, Stefan D. Anker, Peter van der Meer, Chim C. Lang, Adriaan A. Voors, Kevin Damman. Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction. Journal of Cardiovascular Translational Research 2024; 17(1) doi: 10.1007/s12265-023-10356-y
|
| 107 |
Raphael Enrique Tiongco, Neil David Cayanan, Michael John Dominguez, Kyll Geonzon, Julie Ann Mercado, Maria Ruth Pineda-Cortel. High triglyceride-glucose index in patients with diabetes mellitus is associated with an increased likelihood of nephropathy development: evidence from a meta-analysis among Asian population. The Egyptian Journal of Internal Medicine 2025; 37(1) doi: 10.1186/s43162-025-00402-3
|
| 108 |
Shahad Saif Khandker, Shoumik Kundu, Farhana Ahmed, Adiba Ayesha Khan, Lamiya Farhin, Farhana Islam, Rahima Begum, Md Jasim Uddin, A. N. M. Mamun-Or-Rashid. Association of Serum Creatinine, Urea, and Glomerular Filtration Rate with the Progression of Diabetic Associated Kidney Complications: A Retrospective Case-Control Study. Current Issues in Molecular Biology 2026; 48(2) doi: 10.3390/cimb48020167
|
| 109 |
Zhengtao Qin, Carl K. Hoh, Emilia S. Olson, Amin Haghighat Jahromi, David J. Hall, Christopher V. Barback, Young-Hyun You, Motoko Yanagita, Kumar Sharma, David R. Vera. Molecular Imaging of the Glomerulus via Mesangial Cell Uptake of Radiolabeled Tilmanocept. Journal of Nuclear Medicine 2019; 60(9) doi: 10.2967/jnumed.118.223727
|
| 110 |
Elfiani Elfiani, Anggelia Puspasari, Zulkhair Ali. Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications 2023; doi: 10.1007/978-3-031-08014-2_59
|
| 111 |
Lay-Harn Gam. Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications 2022; doi: 10.1007/978-3-030-81303-1_42-1
|
| 112 |
Qijin Zhu, Xiangming Qi, Yonggui Wu, Kun Wang. Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus. International Urology and Nephrology 2016; 48(11) doi: 10.1007/s11255-016-1345-5
|
| 113 |
Ndubuisi V Nwanonenyi, Chuba k Ijoma, Ejike Arodiwe, Maris-Stella I Nwanonenyi, Chidinma Nebo. Diagnostic Performance of Cystatin C in the Early Detection of Diabetic Kidney Disease at the University of Nigeria Teaching Hospital, Ituku-Ozalla. Cureus 2024; doi: 10.7759/cureus.72230
|
| 114 |
Zhila Semnani-Azad, Windy Z N Wang, David E C Cole, Luke W Johnston, Betty Y L Wong, Lei Fu, Ravi Retnakaran, Stewart B Harris, Anthony J Hanley. Urinary Vitamin D Binding Protein: A Marker of Kidney Tubular Dysfunction in Patients at Risk for Type 2 Diabetes. Journal of the Endocrine Society 2024; 8(3) doi: 10.1210/jendso/bvae014
|
| 115 |
Ritu Dahiya, Prabhnain Kaur, Kanika Goyal, Ramesh K. Goyal, Ayushi Singh, Kalicharan Sharma. Uncovering the Impact of MMP-9 and TIMPs in Diabetic Nephropathy: A Review on Bioflavonoids in Disease Management. Current Nutraceuticals 2025; 6 doi: 10.2174/0126659786333625250114080734
|
| 116 |
N Lakshmanna, N Harini Devi, Aparna R. Bitla, Alok Sachan, V Sivakumar, PVLN Srinivasa Rao. Evaluation of Four Novel Biomarkers for Diagnosing of Normoalbuminuric Diabetic Nephropathy in a South Indian Population. Saudi Journal of Kidney Diseases and Transplantation 2025; 36(1-6) doi: 10.4103/sjkdt.sjkdt_252_21
|
| 117 |
Nanthini Jayabalan, Flavio Carrion, Kriti Joshi, Tony Huynh, Carlos Salomon. Unlocking beta cell health: The clinical potential of extracellular vesicles in type 1 diabetes. Clinical and Translational Medicine 2026; 16(5) doi: 10.1002/ctm2.70700
|
| 118 |
Agnieszka Żyłka, Paulina Dumnicka, Beata Kuśnierz-Cabala, Agnieszka Gala-Błądzińska, Piotr Ceranowicz, Jakub Kucharz, Anna Ząbek-Adamska, Barbara Maziarz, Ryszard Drożdż, Marek Kuźniewski. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients. Mediators of Inflammation 2018; 2018 doi: 10.1155/2018/7659243
|